ITM secures 25M euros in a private equity funding round

By AuntMinnieEurope.com staff writers

June 14, 2021 -- German radiopharmaceutical group ITM Isotope Technologies Munich has secured 25 million euros in a private equity funding round that it plans to put toward oncologic radioisotope research and development.

The funds add to ITM's coffers: In April, it announced a 90-million-euro convertible loan agreement.

The company's lead radioisotope candidate is Lu-177 Edotreotide, which is in a phase III trial for gastroenteropancreatic neuroendocrine tumors, it said.


Copyright © 2021 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: